Medicine – Alport Syndrome

Alport syndrome is an inherited disorder caused by abnormalities in type IV collagen, an important structural component of basement membranes. It primarily affects the glomerular basement membrane of the kidney, but also the inner ear and eyes.

The classic clinical pattern is:

Persistent haematuria + progressive kidney disease + sensorineural hearing loss.

1. Genetic Basis

The most common form of Alport syndrome is:

X-linked Alport syndrome.

It is usually caused by pathogenic variants in the:

COL4A5 gene.

This gene encodes part of type IV collagen.

2. Inheritance Pattern

The original note states:

“X-linked dominant.”

This reflects older terminology.

Modern classification usually describes the common form simply as:

X-linked Alport syndrome.

There are also:

Autosomal recessive forms.

Autosomal dominant forms.

These usually involve other type IV collagen genes such as:

COL4A3 and COL4A4.

3. Type IV Collagen

Type IV collagen is a major structural component of:

Basement membranes.

It is particularly important in the:

Glomerular basement membrane.

Cochlea of the inner ear.

Lens and other ocular structures.

Therefore, a collagen defect can produce:

Renal + auditory + ocular abnormalities.

4. Glomerular Basement Membrane

The glomerular basement membrane, or:

GBM,

forms an important part of the renal filtration barrier.

In Alport syndrome, abnormal type IV collagen makes the GBM structurally abnormal and progressively unstable.

This leads initially to:

Haematuria

and later to:

Proteinuria and progressive renal impairment.

5. Early Renal Presentation

The earliest and most common renal feature is:

Persistent microscopic haematuria.

This may begin in:

Childhood.

Some patients may occasionally develop visible haematuria, particularly during:

Intercurrent infections.

6. Microscopic Haematuria

Microscopic haematuria may be present for years before renal function declines.

This is an important diagnostic clue, especially when combined with:

Family history of renal disease

or

Sensorineural deafness.

7. Proteinuria

As glomerular damage progresses, patients may develop:

Proteinuria.

This often indicates more advanced renal involvement than isolated haematuria.

Increasing proteinuria is associated with a greater risk of:

Progressive chronic kidney disease.

8. Chronic Kidney Disease

Progressive glomerular scarring eventually leads to:

Chronic kidney disease, or CKD.

The older term:

CRF – chronic renal failure

is better replaced with:

CKD.

Advanced disease may progress to:

End-stage kidney disease, or ESKD.

9. Sensorineural Hearing Loss

A major extrarenal feature is:

Sensorineural hearing loss.

This usually affects:

High-frequency hearing

and often develops during:

Late childhood or adolescence

in more severely affected patients.

10. Why Hearing Loss Occurs

Type IV collagen is important in basement membranes of the:

Cochlea.

Abnormal collagen disrupts normal cochlear function.

Therefore:

Alport syndrome → sensorineural deafness, not conductive deafness.

11. Hearing Loss and Kidney Disease

The combination:

Persistent microscopic haematuria + sensorineural hearing loss

should strongly suggest:

Alport syndrome.

This is particularly important in a male patient with a family history of:

Renal failure.

12. Ocular Abnormalities

The original notes do not mention the eye, but ocular abnormalities are an important part of Alport syndrome.

Classical findings include:

Anterior lenticonus.

Retinal flecks.

Other retinal abnormalities.

13. Anterior Lenticonus

Anterior lenticonus is highly characteristic.

The anterior surface of the lens becomes:

Cone-shaped or protruding.

It may cause:

Progressive visual impairment.

This finding strongly supports the diagnosis of Alport syndrome.

14. Retinal Changes

Patients may also develop:

Perimacular retinal flecks.

These are usually not the major cause of visual loss but can provide another diagnostic clue.

15. Renal Histology

Light microscopy may be relatively nonspecific, especially early in disease.

More characteristic abnormalities are seen on:

Electron microscopy.

16. Electron Microscopy

The glomerular basement membrane may show:

Irregular thickening and thinning.

Splitting and lamellation.

This produces the classic:

“Basket-weave” appearance.

17. Basket-Weave GBM

The basket-weave appearance results from:

Splitting and layering of the lamina densa of the GBM.

This is a classic pathological clue to:

Alport syndrome.

18. Early GBM Changes

In earlier disease, the GBM may show:

Diffuse thinning.

Later it becomes more irregular with:

Thickening, splitting, and lamellation.

Therefore, pathology may evolve as disease progresses.

19. Collagen Immunostaining

Modern diagnosis may also use:

Type IV collagen immunostaining

on kidney or skin tissue in selected cases.

However, increasingly, diagnosis is established by:

Genetic testing.

20. Genetic Testing

Genetic testing can identify pathogenic variants in:

COL4A3.

COL4A4.

COL4A5.

This can:

Confirm the diagnosis.

Clarify inheritance.

Help assess family members.

Guide genetic counselling.

21. Males with X-Linked Alport Syndrome

Males with pathogenic COL4A5 variants are generally more severely affected because they have:

Only one X chromosome.

Traditionally, affected males were said to:

All develop renal failure.

This is too absolute.

22. Renal Prognosis in Males

Many affected males do develop:

Progressive CKD and ESKD.

However, the:

Age of progression

and

Severity

vary considerably depending on the specific genetic variant.

Therefore, not every male reaches kidney failure at the same age, and some milder variants progress much more slowly.

23. Females with X-Linked Alport Syndrome

The original note states:

“Females: minor abnormalities only.”

This is also too simplistic.

Females are often less severely affected than males, but they are not simply unaffected carriers.

24. Renal Disease in Females

Females may develop:

Persistent microscopic haematuria.

Proteinuria.

Hypertension.

Progressive CKD.

A minority may eventually develop:

ESKD.

Therefore, women with X-linked Alport syndrome require proper long-term follow-up.

25. Why Females Are Variable

Females have two X chromosomes.

Because of:

X-chromosome inactivation,

the proportion of cells expressing the abnormal COL4A5 allele varies.

This contributes to major variation in disease severity between females.

26. Autosomal Recessive Alport Syndrome

Autosomal recessive disease is usually caused by pathogenic variants affecting both copies of:

COL4A3

or

COL4A4.

Both males and females can be:

Severely affected.

The clinical pattern can resemble severe X-linked disease.

27. Autosomal Dominant Alport Syndrome

Autosomal dominant forms usually involve one pathogenic variant in:

COL4A3

or

COL4A4.

These may cause:

Persistent haematuria

with variable:

Proteinuria and CKD progression.

Disease is often milder and later in onset than severe X-linked or autosomal recessive forms, although substantial CKD can still occur.

28. Family History

A useful family history may include:

Microscopic haematuria.

Progressive kidney failure.

Dialysis or transplantation at a young age.

Sensorineural hearing loss.

However, absence of an obvious family history does not exclude the disease because new pathogenic variants and unrecognised mild disease can occur.

29. Differential Diagnosis

Persistent familial haematuria can also occur with:

Thin basement membrane nephropathy / COL4A-related disease.

IgA nephropathy.

Other hereditary glomerular disorders.

Modern understanding increasingly recognises overlap among:

COL4A3, COL4A4, and COL4A5-related disorders.

30. Thin Basement Membrane Disease

Some patients with heterozygous COL4A3 or COL4A4 variants were historically labelled as having:

Thin basement membrane nephropathy.

These patients may have isolated haematuria, but some can develop:

Proteinuria and CKD.

Thus the distinction from the broader Alport spectrum is less absolute than older teaching suggested.

31. Treatment Principles

There is no simple treatment that replaces defective collagen.

Management therefore aims to:

Slow renal progression.

Reduce proteinuria.

Control blood pressure.

Monitor hearing and vision.

Provide genetic counselling.

32. ACE Inhibitors

One of the most important renal treatments is:

ACE inhibitor therapy

especially once albuminuria or proteinuria develops.

ACE inhibitors reduce:

Intraglomerular pressure.

Proteinuria.

They can slow progression of kidney disease.

33. ARBs

If an ACE inhibitor is not tolerated, an:

Angiotensin II receptor blocker, or ARB

may be considered.

As in other proteinuric kidney diseases:

ACE inhibitor and ARB should not routinely be combined.

34. Blood-Pressure Control

Good blood-pressure control is important because hypertension accelerates:

Glomerular damage

and

Loss of renal function.

Patients require regular monitoring of:

Blood pressure.

Urinary albumin/protein.

Creatinine and eGFR.

35. Hearing Management

Patients should undergo:

Audiological assessment

when clinically appropriate.

Progressive sensorineural hearing loss may require:

Hearing aids

or other specialist hearing support.

36. Eye Assessment

Ophthalmological assessment may identify:

Anterior lenticonus.

Retinal abnormalities.

Treatment depends on the specific ocular complication.

37. Kidney Transplantation

Patients who progress to ESKD may undergo:

Kidney transplantation.

Transplant outcomes are generally good.

The transplanted kidney contains normal type IV collagen and is not affected by the inherited GBM defect.

38. Anti-GBM Disease after Transplantation

A rare complication after transplantation is the development of:

Anti-glomerular basement membrane antibodies.

This can cause:

Anti-GBM nephritis in the transplanted kidney.

It is uncommon but classically associated with some severely affected Alport patients.

39. Genetic Counselling

Because Alport syndrome is inherited, patients and families may benefit from:

Genetic counselling.

This can help clarify:

Inheritance risk.

Testing of relatives.

Reproductive implications.

Need for renal surveillance in family members.

40. Alport Syndrome – Note Form

Cause:

Inherited type IV collagen disorder.

Genes:

COL4A5 most common X-linked form.

COL4A3 and COL4A4 in autosomal forms.

Main renal feature:

Persistent microscopic haematuria.

Progression:

Haematuria → proteinuria → CKD → possible ESKD.

Hearing:

Sensorineural deafness.

Eyes:

Anterior lenticonus.

Retinal flecks.

Biopsy / electron microscopy:

GBM thinning early.

Later irregular thickening, splitting and lamellation.

Classic:

Basket-weave appearance.

Males with X-linked disease:

Usually more severely affected.

Many progress to ESKD, but age and severity vary.

Females with X-linked disease:

Often milder, but may develop haematuria, proteinuria, hypertension, CKD and occasionally ESKD.

They are not always just mildly affected carriers.

Treatment:

ACE inhibitor or ARB where indicated.

Good blood-pressure control.

Renal monitoring.

Hearing and eye follow-up.

Kidney transplantation for ESKD.

Genetic counselling.

41. Important Corrections to the Original Notes

The statement:

“Alport syndrome is X-linked dominant”

is incomplete.

The most common form is:

X-linked Alport syndrome due to COL4A5,

but autosomal recessive and autosomal dominant forms also occur.

The statement:

“All males develop renal failure”

is too absolute.

A better description is:

Affected males are generally at much higher risk of progressive CKD and ESKD, but severity and age of onset vary with genotype.

The statement:

“Females have minor abnormalities only”

is incorrect.

Females may develop:

Proteinuria, hypertension, progressive CKD, and occasionally ESKD.

Therefore, affected women require long-term monitoring.

The older term:

CRF

is better replaced with:

CKD – chronic kidney disease.

Key Clinical Pattern

Remember:

ALPORT = KIDNEY + EAR + EYE.

The classic combination is:

PERSISTENT MICROSCOPIC HAEMATURIA + SENSORINEURAL DEAFNESS + FAMILY HISTORY OF RENAL FAILURE.

For pathology:

TYPE IV COLLAGEN DEFECT → ABNORMAL GBM → BASKET-WEAVE APPEARANCE ON ELECTRON MICROSCOPY.

For genetics:

COL4A5 → MOST COMMON X-LINKED FORM.

And the important modern correction is:

MALES ARE USUALLY MORE SEVERELY AFFECTED, BUT FEMALES CAN ALSO DEVELOP SIGNIFICANT CKD.